11. November 2022

"Investments in biotechs require a lot of patience and trust" - Article in GoingPublic

"Investments in biotechs require a lot of patience and trust" - Article in GoingPublic

"Investments in biotechs require a lot of patience and trust" - Article in GoingPublic

Interview with CEO Andreas Grassauer and CFO Pascal Schmidt

Article in GoingPublic (German only)